Background: Acute conjunctivitis is one of the leading diagnosis in patients attending Ophthalmology outpatient departments of all healthcare settings. According to a survey done by National Health Institute (NIH) of United States, it accounts to around 1 % of all patients coming to primary care and emergency room visits. The available data, so far shows that Covid 19 infection causes conjunctivitis (pink eye syndrome) in 1-3 % of infected individuals. Ocular symptoms related to conjunctivitis and keratitis are the most common manifestations seen. The drugs predominantly used to treat these are topical and systemic anti-inflammatory drugs, topical antibiotics, lubricants and anti-histaminics. Objectives: To obtain data on the current prescription trends in the management of acute conjunctivitis in outpatient department of Ophthalmology with an aim to know the trend of cases of conjunctivitis during covid pandemic and various treatment modalities. Methods: This prospective, observational, cross sectional study was conducted by the department of Pharmacology in the Department of Ophthalmology of Santosh Medical College, Ghaziabad. The prescriptions of 600 patients were recorded and analysed. The prescription details of patients who had symptoms of conjunctivitis (redness, pain, watering, mucopurulent discharge, swelling, itching , photophobia ) were noted excluding patients of cataract, surgeries or any intervention. The data was analysed using descriptive statistics